$ cat ./records/gates-foundation-announces-33-million-tuberculosis-partnership-wi-2009.txt
Gates Foundation Announces $33 Million Tuberculosis Partnership with China
[RECORD.TXT] · cat --full
Gates and Chinese Health Minister Chen Zhu announced a five-year, $33 million partnership to improve tuberculosis diagnosis, treatment, and drug-resistance monitoring across China. China accounts for approximately 1.5 million new TB cases annually. The program deployed faster diagnostics and improved treatment regimens in high-burden provinces and became a model for large-scale public-private health partnerships between international foundations and the Chinese government.
Source: https://www.gatesfoundation.org/ideas/articles/2009/04/new-us-china-health-initiative
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Becomes One of CGIAR's Largest Funders — Committing Hundreds of Millions to International Crop Research
Next →
Invests in Carbon Engineering Direct Air Capture Startup
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.